ASTRAZENECA- TOZORAKIMAB 300MG SHOWS REDUCTION IN MODERATE, SEVERE… — First Squawk — TG.ME

ASTRAZENECA- TOZORAKIMAB 300MG SHOWS REDUCTION IN MODERATE, SEVERE COPD EXACERBATIONS IN OVERALL CURRENT, FORMER SMOKER POPULATION BY 29% IN TITANIA
(@FirstSquaw)
September 8, 2026 206 2